Upper gastrointestinal malignancies in 2017: current perspectives and future approaches

Autor Solomon, Benjamin L, Garrido-Laguna, Ignacio
Vydáno v Future Oncol (2018)

Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer

Autor Patel, Shiven B, Gill, David, Garrido-Laguna, Ignacio
Vydáno v Onco Targets Ther (2015)

Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies

Autor Au, Trang H., Wang, Kai, Stenehjem, David, Garrido-Laguna, Ignacio
Vydáno v J Gastrointest Oncol (2017)

Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction

Autor Florou, Vaia, Puri, Sonam, Garrido-Laguna, Ignacio, Wilky, Breelyn A.
Vydáno v Ann Transl Med (2021)

Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle

Autor Gajiwala, Snehal, Torgeson, Anna, Garrido-Laguna, Ignacio, Kinsey, Conan, Lloyd, Shane
Vydáno v J Gastrointest Oncol (2018)

Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line c...

Autor Nevala-Plagemann, Christopher, Moser, Justin, Gilcrease, Glynn Weldon, Garrido-Laguna, Ignacio
Vydáno v ESMO Open (2019)

Large database utilization in health outcomes research in pancreatic cancer: an update

Autor Torgeson, Anna, Tao, Randa, Garrido-Laguna, Ignacio, Willen, Benjamin, Dursteler, Amy, Lloyd, Shane
Vydáno v J Gastrointest Oncol (2018)

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins

Autor Torgeson, Anna, Garrido-Laguna, Ignacio, Tao, Randa, Cannon, George M, Scaife, Courtney L, Lloyd, Shane
Vydáno v ESMO Open (2018)

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer

Autor Gruhl, Joshua D., Garrido‐Laguna, Ignacio, Francis, Samual R., Affolter, Kajsa, Tao, Randa, Lloyd, Shane
Vydáno v Cancer Med (2020)

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency

Autor Rengifo-Cam, William, Jasperson, Kory, Garrido-Laguna, Ignacio, Colman, Howard, Scaife, Courtney, Samowitz, Wade, Samadder, N. Jewel
Vydáno v ACG Case Rep J (2017)

Treatment Rechallenge With Checkpoint Inhibition in Patients With Mismatch Repair–Deficient Pancreatic Cancer After Planned Treatment Interruption

Autor Florou, Vaia, Nevala-Plagemann, Christopher, Barber, Kristin E., Mastroianni, Jenna N., Cavalieri, Courtney C., Garrido-Laguna, Ignacio
Vydáno v JCO Precis Oncol (2020)

N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012

Autor Garrido-Laguna, Ignacio, Tometich, Danielle, Hu, Nan, Ying, Jian, Geiersbach, Katherine, Whisenant, Jonathan, Wang, Kai, Ross, Jeffrey S., Sharma, Sunil
Vydáno v Oncoscience (2015)

Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy

Autor Nevala-Plagemann, Christopher, Francis, Samual, Cavalieri, Courtney, Tao, Randa, Whisenant, Jonathan, Glasgow, Robert, Scaife, Courtney, Lloyd, Shane, Garrido-Laguna, Ignacio
Vydáno v ESMO Open (2018)

A framework for genomic biomarker actionability and its use in clinical decision making

Autor Vidwans, Smruti J., Turski, Michelle L., Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Subbiah, Vivek, Rodon, Jordi, Kurzrock, Razelle
Vydáno v Oncoscience (2014)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

Autor Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Vydáno 2011

Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Treated in a Phase I Clinic

Autor Janku, Filip, Tsimberidou, Apostolia M., Wang, Xuemei, Hong, David S., Naing, Aung, Gong, Jing, Garrido-Laguna, Ignacio, Parsons, Henrique A., Zinner, Ralph G., Kurzrock, Razelle
Vydáno 2011

Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer

Autor Vaishnavi, Aria, Scherzer, Michael T., Kinsey, Conan G., Parkman, Gennie L., Truong, Amanda, Ghazi, Phaedra, Schuman, Sophia, Battistone, Benjamin, Garrido-Laguna, Ignacio, McMahon, Martin
Vydáno v Cell Rep (2020)

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

Autor Garrido-Laguna, Ignacio, Hong, David S., Janku, Filip, Nguyen, Ly M., Falchook, Gerald S., Fu, Siqing, Wheler, Jenifer J., Luthra, Rajyalakshmi, Naing, Aung, Wang, Xuemei, Kurzrock, Razelle
Vydáno 2012

A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer

Autor Hidalgo, Manuel, Bruckheimer, Elizabeth, Rajeshkumar, N.V., Garrido-Laguna, Ignacio, De Oliveira, Elizabeth, Rubio-Viqueira, Belen, Strawn, Steven, Wick, Michael J., Martell, James, Sidransky, David
Vydáno v Mol Cancer Ther (2011)

The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA

Autor Nix, David A., Hellwig, Sabine, Conley, Christopher, Thomas, Alun, Fuertes, Carrie L., Hamil, Cindy L., Bhetariya, Preetida J., Garrido-Laguna, Ignacio, Marth, Gabor T., Bronner, Mary P., Underhill, Hunter R.
Vydáno v PLoS One (2020)